European Archives - Page 583 of 1005 - European Medical Journal

Nanoparticle-Immunotherapy as a Novel Treatment for Lung Cancer

INHALABLE nanoparticles have been shown success in animal models to treat lung cancer. The study, carried out by a team supervised by Professor Dawen Zhao…

Building a R&D strategy for the modern age

Low levels of return on investment in R&D is an issue that has been bubbling beneath the surface of pharmaceutical companies for some time and the situation is coming to a head, threatening the industry’s future

Creating the patient-centred trial

Patient recruitment and retention remain the biggest challenges in clinical studies, it is surely time for industry to trial a new approach.

The history of medical affairs

Learn about the origins of the medical affairs function, how far it’s come and where it may be heading in the future as key proprietor of patient centricity.

Ipsen’s Isabelle Bocher-Pianka on patient-centric pharma evolution

Isabelle Bocher-Pianka, Chief Patient Affairs Officer, Global Medical Affairs, Ipsen shares her thoughts on pharma’s mission to help improve patient lives, challenges that hinder patient centricity and seeking knowledge across industries.

Pharma: the social butterfly

The internet is a jungle, tangled and overgrown, dense with information overload. Among the unkempt chaos lies social media: a treasure trove of possibilities for the pharmaceutical industry.

ESC 2019 – Interview – Dr Çetin Erol

An interview with Dr Çetin Erol, İbn-i Sina Hospital, Faculty of Medicine, Department of Cardiology, Ankara University, Ankara, Turkey, at this year’s ESC…

Will NASA Exercise Programmes Astronomically Improve Chemotherapy Patient Fitness?

Astronauts experience physical stress while in space and have a rigorous training programme prior, during, and after their expedition…

New Method to More Accurately Estimate Breast Cancer Survival Rates

Survival rates for those with later-stage cancer are progressively increasing with better treatment and earlier diagnosis…

Psoriasis and Atopic Dermatitis: Addressing Therapeutic Paradigms by Learning from Each Other

Psoriasis and AD are chronic, systemic inflammatory diseases of the skin characterised by upregulation of proinflammatory cytokines…